CDC

President Obama’s decree proclaiming April 4 – 10 National Public Health Week focuses on several key objective: stemming the tide of infectious disease like Zika; improving access to healthcare domestically and globally; promoting healthy behaviors in adolescents; preventing opioid and illicit drug abuse; decreasing gun violence; addressing climate change-related health issues; and improving access to mental health resources. National Public Health week is an opportunity to reflect on the pivotal role public health research and practice play in advancing the wellbeing of Americans and populations across the globe, and recognize the individuals, organizations and agencies that carry out...
Dear Research Advocate: As task force meetings for Vice President Biden’s “moonshot” initiative began this week, a new public opinion survey commissioned by Research!America showed that 50% of Americans favor a tax increase to fund cancer research. While this manner of funding the moonshot is not currently on the table, the survey finding underscores the high priority Americans place on curing cancer. The President told Majority Leader McConnell and Speaker Ryan that assuring resources for research, cancer in particular, is one of his five priorities for working across the aisle this year. His FY17 budget proposal -- scheduled for release next Tuesday -- will reportedly request additional...
This was an exceptional year for publicly-funded research projects. Investments in science led to a greater understanding of preventing and treating disease such as using genetic variants to identify people at risk for coronary heart disease and tailoring breast cancer treatments to avoid the need for chemotherapy. The National Institutes of Health (NIH) also supported the work of three Nobel Prize winners and clinical advances in cancer, heart disease, MS and many other conditions. The National Science Foundation (NSF) funded interdisciplinary projects including one that led to a holistic approach to strengthening the security and effectiveness of mobile medical applications . Evidence-...
Dear Research Advocate, This holiday season, Congress has delivered a most welcome package with plenty of trimmings for patients and all of us who care about the future of health. The bipartisan deal-making is complete. A final short-term spending measure, expiring Tuesday, December 22, allows the House and Senate time to review and pass a spending bill and tax package before adjourning for the year. These two major pieces of legislation represent a real win for research; the jumpstart we need to restore the NIH budget to robust annual growth and fuel a new era of medical innovation and global leadership in both public and private sectors. As federal policymakers consider how to vote on...
Dear Research Advocate, The current continuing resolution (CR) expires tomorrow. Congress has yet to reach agreement on FY16 appropriations, so they will buy more time to hammer out a funding package by passing another CR lasting til midnight Wednesday, December 16. The major sticking points at this moment are additional policy riders attached to the funding omnibus, spanning the spectrum from immigration and refugees to labor and environmental issues. As it looks right now, some research-related budgets stand to gain, while others face a less positive fate. There’s more on NIH in my interview with The Atlantic , and we continue to press for increases for CDC, FDA, AHRQ and NSF. Social,...
Dear Research Advocate, I hope you’ll pardon this weekly message arriving a few days early. This week gives each American a special opportunity to reflect on all that makes us grateful. I am thankful for each of you who places an emphasis on incorporating advocacy for research, public health, and medical progress into your daily lives. I am also especially thankful for all those who took time yesterday to celebrate Public Health Thank You Day . The conversation was robust on social and traditional media with messages honoring public health professionals and expressing gratitude for the multi-faceted benefits of public health research and practice. More than 800 organizations and individuals...
Dear Research Advocate, "Never Settle" is the empowering guiding theme used by Janssen Pharmaceuticals to underscore the emphasis the company places on innovation to benefit patients. In my visit to their Spring House, PA, site today to participate in a worldwide town hall, I was struck by how their theme epitomizes the advocacy drive and determination of Research!America and all our partners in advocacy for research. I was glad to report to Janssen's teams that more and more members of Congress are championing research and innovation to benefit patients worldwide. Consider the comments of Chairman Roy Blunt (R-MO) about the FY16 Senate “Labor-H” appropriations draft, which reportedly...
Over the course of his last few weeks before retiring, Speaker Boehner worked with fellow House and Senate leaders and the President to fashion a budget deal that increases the nation’s debt limit and provides an additional $80 billion above sequestration-level spending caps. Both non-defense and defense programs will receive $25 billion more in fiscal year 2016 (FY16) and $15 billion more in FY 2017. The House has passed this budget plan, and the Senate is expected to follow suit by Tuesday. See our statement . Passing this deal is step one. Step two is allocating top-line budget numbers across the 12 appropriations subcommittees (these allocations are known as “302(b)s”). This will likely...
Dear Research Advocate, The Nobel prize winners announced this week showcase the role of both private sector (William Campbell’s work at Merck) and federal funding (Paul Modrich’s and Aziz Sancar's NIH and NSF grants) in driving scientific progress, and more broadly, the profound return science delivers to our nation and the world. Read our statements on the winners . The next few weeks are crucial for science funding and policies. Congressional leadership is working with the President to arrive at a budget deal that lifts the sequester caps, allowing for increases in NIH and other research agencies. If a deal lifting the caps is not made before Speaker Boehner retires, the new speaker (...
Dear Research Advocate: Pope Francis’ visit to Washington has been a breath of fresh air, but now Congress must get to work and reach a funding agreement that avoids a government shutdown beginning October 1st. Didn’t we learn from the last shutdown, just two years ago? Young patients were turned away from clinical trials at NIH. Disease outbreaks were not monitored because CDC epidemiologists were furloughed. Drugs, devices and other medical products pending FDA approval were delayed. All of this -- and much, much more -- was then and is now, entirely avoidable. Advocates should not be complacent; a government shutdown screams “broken government,” and should not even be on the table...

Pages

Sidebar Quote

If concerted, long-term investments in research are not made, America will lose an entire generation of young scientists.
Brenda Canine, PhD; McLaughlin Research Institute, Montana